Computed tomography pulmonary angiography (CTPA) is the imaging modality of choice for the diagnosis of acute pulmonary embolism (PE). With computed tomography pulmonary perfusion (CTPP) additional information on lung perfusion can be assessed, but its value in PE risk stratification is unknown. We aimed to evaluate the correlation between CTPP-assessed perfusion defect score (PDS) and clinical presentation and its predictive value for adverse short-term outcome of acute PE.  This was an exploratory, observational study in 100 hemodynamically stable patients with CTPA-confirmed acute PE in whom CTPP was performed as part of routine clinical practice. We calculated the difference between the mean PDS in patients with versus without chest pain, dyspnea, and hemoptysis and 7-day adverse outcome. Multivariable logistic regression analysis and likelihood-ratio test were used to assess the added predictive value of PDS to CTPA parameters of right ventricle dysfunction and total thrombus load, for intensive care unit admission, reperfusion therapy and PE-related death.  We found no correlation between PDS and clinical symptoms. PDS was correlated to reperfusion therapy (  = 4 with 16% higher PDS, 95% confidence interval [CI]: 3.5-28%) and PE-related mortality (  = 2 with 22% higher PDS, 95% CI: 4.9-38). Moreover, PDS had an added predictive value to CTPA assessment for PE-related mortality (from Chi-square 14 to 19,  = 0.02).  CTPP-assessed PDS was not correlated to clinical presentation of acute PE. However, PDS was correlated to reperfusion therapy and PE-related mortality and had an added predictive value to CTPA-reading for PE-related mortality; this added value needs to be demonstrated in larger studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875679PMC
http://dx.doi.org/10.1055/s-0041-1723782DOI Listing

Publication Analysis

Top Keywords

pe-related mortality
16
tomography pulmonary
12
reperfusion therapy
12
pds correlated
12
pds
10
computed tomography
8
pulmonary perfusion
8
outcome acute
8
acute pulmonary
8
pulmonary embolism
8

Similar Publications

The purpose of this study is to conduct a literature review on the current role of computed tomography pulmonary angiography (CTPA) in the diagnosis and prognosis of pulmonary embolism (PE). It addresses key topics such as the quantification of the thrombotic burden, its role as a predictor of mortality, new diagnostic techniques that are available, the possibility of analyzing the thrombus composition to differentiate its evolutionary stage, and the applicability of artificial intelligence (AI) in PE through CTPA. The only finding from CTPA that has been validated as a prognostic factor so far is the right ventricle/left ventricle (RV/LV) diameter ratio being >1, which is associated with a 2.

View Article and Find Full Text PDF

Lateral Flow Assay for Preeclampsia Screening Using DNA Hairpins and Surface-Enhanced Raman-Active Nanoprobes Targeting hsa-miR-17-5p.

Biosensors (Basel)

November 2024

Department of Biomedical Engineering, Texas A&M University, 5045 Emerging Technologies Building, College Station, TX 77843, USA.

Article Synopsis
  • - Preeclampsia (PE) is a serious pregnancy complication that often goes unnoticed until later trimesters, leading to risks for mothers and babies, especially in low- and middle-income countries where healthcare resources are limited.
  • - Recent research identifies variations in hsa-miR-17-5p levels as a potential early marker to differentiate between women with and without PE during the first trimester, indicating the need for early screening.
  • - A new lateral-flow assay (LFA) has been developed to measure hsa-miR-17-5p levels with high specificity and sensitivity using advanced detection methods, aiming to improve early detection and accessibility of testing worldwide.
View Article and Find Full Text PDF
Article Synopsis
  • Acute pulmonary embolism (PE) poses a significant risk of death in patients with active cancer; this study examines how cancer affects treatment choices and outcomes.
  • Out of 872 examined PE patients, 14.8% had active malignancy, with varying treatment approaches and poorer long-term outcomes for those with cancer.
  • Despite higher mortality rates and challenges, catheter-based treatments show promise for effectively managing PE in cancer patients while maintaining manageable bleeding risks.
View Article and Find Full Text PDF
Article Synopsis
  • Extracorporeal membrane oxygenation (ECMO) may be necessary for some patients with severe pulmonary embolism (PE), but its clinical outcomes are not well understood.
  • *In a study analyzing data from 2035 patients with acute PE, 76 required ECMO, with findings indicating high rates of cardiac arrest (88.2%) at diagnosis and a 30-day death rate of 30.3%, all related to PE.
  • *The research highlighted significant complication rates, including a 54% incidence of major bleeding, suggesting the need for improved management strategies and future clinical trials.
View Article and Find Full Text PDF

Sex, Racial/Ethnic, and Regional Disparities in Pulmonary Embolism Mortality Trends in the USA, 1999-2020.

J Racial Ethn Health Disparities

October 2024

Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210Th Street, Bronx, NY, USA.

Background: While the National Institutes of Health emphasize integrating sex as a biological variable into research, specific considerations of sex-related differences in pulmonary embolism (PE) mortality trends remain scarce. This study examines sex-based PE mortality trends across regional and demographic groups in the USA from 1999 to 2020.

Methods: A retrospective analysis of National Center for Health Statistics mortality data from 1999 to 2020 was conducted.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!